These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of the cholesterol biosynthesis inhibitor ay9944 on organotypic cultures ofmouse spinal cord. Retarded myelinogenesis and induction of cytoplasmic inclusions. Kim SU Lab Invest; 1975 Jun; 32(6):720-8. PubMed ID: 50497 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study of myelin isolated from brains of young and adult rats treated with an inhibitor of cholesterol biosynthesis]. Rawlins FA; López-Jiménez C Acta Cient Venez; 1979; 30(6):551-8. PubMed ID: 95381 [No Abstract] [Full Text] [Related]
4. Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis. II. AY-9944 and AY-9944 plus zuclomiphene. Ramsey RB; Fredericks M Biochem Pharmacol; 1977 Jun; 26(12):1169-73. PubMed ID: 70208 [No Abstract] [Full Text] [Related]
5. Increment in sodium and potassium dependent adenosine triphosphatase of brain microsomal fraction from rats treated with the cholesterol biosynthesis inhibitor AY 9944. Proverbio F; Rawlins FA Mol Pharmacol; 1978 Sep; 14(5):911-9. PubMed ID: 82201 [No Abstract] [Full Text] [Related]
6. Expression of Sonic Hedgehog downstream genes is modified in rat embryos exposed in utero to a distal inhibitor of cholesterol biosynthesis. Gofflot F; Gaoua W; Bourguignon L; Roux C; Picard JJ Dev Dyn; 2001 Feb; 220(2):99-111. PubMed ID: 11169843 [TBL] [Abstract][Full Text] [Related]
7. Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis III. Zuclomiphene in combination with AY9944 and triparanol. Ramsey RB Biochem Pharmacol; 1978; 27(12):1637-40. PubMed ID: 81057 [No Abstract] [Full Text] [Related]
9. Combined effects of AY9944 and plasma LDL (or whole plasma) on lymphocyte blastic transformation. Rampini C; Adriambinintsoa C; Barbu V; Maziere JC; Maziere C; Roux C Biochem Pharmacol; 1989 Nov; 38(21):3887-91. PubMed ID: 2480790 [No Abstract] [Full Text] [Related]
10. Niemann-Pick disease-like inclusions caused by a hypocholesteremic agent. Sakuragawa M Invest Ophthalmol; 1976 Dec; 15(12):1022-7. PubMed ID: 62729 [TBL] [Abstract][Full Text] [Related]
11. Changes in brain hydrolytic enzyme activities in rats treated with cholesterol biosynthesis inhibitor, AY9944. Igarashi M; Suzuki K; Chen SM Brain Res; 1975 Jun; 90(1):97-114. PubMed ID: 48406 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of sterol and DNA synthesis in peripheral blood lymphocytes by AY9944. Kay G; Wilce PA Biochem Biophys Res Commun; 1983 Jan; 110(1):82-7. PubMed ID: 6188453 [TBL] [Abstract][Full Text] [Related]
13. [Incorporation of 3H-thymidine in Wistar rat embryos treated with AY 9944]. Roux C; Rapin J; Dupuis R; Aubry MM C R Seances Soc Biol Fil; 1975; 169(1):24-6. PubMed ID: 52389 [TBL] [Abstract][Full Text] [Related]
14. EFFECT OF A NOVEL HYPOCHOLESTEROLEMIC AGENT, TRANS-1,4-BIS-(2-CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE DIHYDROCHLORIDE (AY-9944) ON ADRENAL MORPHOLOGY. MARTON AV; GRESELIN E; GIVNER M; VOITH K Endocrinology; 1964 Oct; 75():469-76. PubMed ID: 14211888 [No Abstract] [Full Text] [Related]
15. The effect of the hypocholesteremic drug, AY 9944 on the synthesis of bile salts in rat liver. Botham KM; Boyd GS Eur J Biochem; 1981 Sep; 118(3):501-5. PubMed ID: 6170514 [TBL] [Abstract][Full Text] [Related]
16. Colorimetric estimate of cholesterogenesis in livers perfused in the presence of trans-1,4-bis-(2-chlorobenzylaminomethyl)-cyclohexane dihydrochloride (AY-9944). Goh EH Biochem Pharmacol; 1979 Oct; 28(19):2969-72. PubMed ID: 92992 [No Abstract] [Full Text] [Related]
17. AY9944 inhibits early activation of phosphatidylinositol metabolism in concanavalin A-stimulated lymphocytes. Rampini C Biochem Pharmacol; 1990 Sep; 40(6):1417-9. PubMed ID: 1698368 [No Abstract] [Full Text] [Related]
18. Marked alteration of sterol metabolism and composition without compromising retinal development or function. Fliesler SJ; Richards MJ; Miller C; Peachey NS Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1792-801. PubMed ID: 10393050 [TBL] [Abstract][Full Text] [Related]
19. [Cholesterol and development]. Roux C; Wolf C; Llirbat B; Kolf M; Mulliez N; Taillemite JL; Cormier V; Le Merrer M; Chevy F; Citadelle D C R Seances Soc Biol Fil; 1997; 191(1):113-23. PubMed ID: 9181133 [TBL] [Abstract][Full Text] [Related]
20. [Experimental Niemann-Pick rat: additional studies on the specificity of the sphingomyelinase reduction in rats treated with AY 9944 (author's transl)]. Watanabe K; Sakuragawa N; Arima M No To Shinkei; 1981 Jun; 33(3):585-93. PubMed ID: 6167277 [No Abstract] [Full Text] [Related] [Next] [New Search]